342 related articles for article (PubMed ID: 31849983)
1. Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential.
Rodriguez-Fernandez S; Murillo M; Villalba A; Perna-Barrull D; Cano-Sarabia M; Gomez-Muñoz L; Aguilera E; Maspoch D; Vazquez F; Bel J; Vives-Pi M
Front Immunol; 2019; 10():2811. PubMed ID: 31849983
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry.
Rodriguez-Fernandez S; Pujol-Autonell I; Brianso F; Perna-Barrull D; Cano-Sarabia M; Garcia-Jimeno S; Villalba A; Sanchez A; Aguilera E; Vazquez F; Verdaguer J; Maspoch D; Vives-Pi M
Front Immunol; 2018; 9():253. PubMed ID: 29491866
[TBL] [Abstract][Full Text] [Related]
3. Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
Garcia-Loza I; Perna-Barrull D; Aguilera E; Almenara-Fuentes L; Gomez-Muñoz L; Greco D; Vila M; Salvado M; Mancera-Arteu M; Olszowy MW; Petriz J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M
J Autoimmun; 2024 May; 145():103196. PubMed ID: 38458075
[TBL] [Abstract][Full Text] [Related]
4. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.
Vorobjova T; Uibo O; Heilman K; Uibo R
World J Gastroenterol; 2015 Jan; 21(2):439-52. PubMed ID: 25593459
[TBL] [Abstract][Full Text] [Related]
5. Stat5b/Ezh2 axis governs high PD-L1 expressing tolerogenic dendritic cell subset in autoimmune diabetes.
Ullah Khan F; Khongorzul P; Gris D; Amrani A
Int Immunopharmacol; 2024 May; 133():112166. PubMed ID: 38678673
[TBL] [Abstract][Full Text] [Related]
6. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
[TBL] [Abstract][Full Text] [Related]
7. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
Front Immunol; 2019; 10():19. PubMed ID: 30723474
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes.
Marin-Gallen S; Clemente-Casares X; Planas R; Pujol-Autonell I; Carrascal J; Carrillo J; Ampudia R; Verdaguer J; Pujol-Borrell R; Borràs FE; Vives-Pi M
Clin Exp Immunol; 2010 May; 160(2):207-14. PubMed ID: 20030670
[TBL] [Abstract][Full Text] [Related]
9. Altered Frequency and Phenotype of HLA-G-Expressing DC-10 in Type 1 Diabetes Patients at Onset and in Subjects at Risk to Develop the Disease.
Amodio G; Mandelli A; Curto R; Rancoita PMV; Stabilini A; Bonfanti R; de Pellegrin M; Bosi E; Di Serio C; Battaglia M; Gregori S
Front Immunol; 2021; 12():750162. PubMed ID: 34659254
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Tolerogenic Features on Dexamethasone-Modulated MPLA-Activated Dendritic Cells by MYC.
García-González PA; Maggi J; Schinnerling K; Sepúlveda-Gutiérrez A; Soto L; Neira O; Mehdi AM; Nel HJ; Pesce B; Aravena O; Molina MC; Catalán D; Thomas R; Verdugo RA; Aguillón JC
Front Immunol; 2019; 10():1171. PubMed ID: 31191540
[TBL] [Abstract][Full Text] [Related]
11. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.
Gleisner MA; Rosemblatt M; Fierro JA; Bono MR
Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264
[TBL] [Abstract][Full Text] [Related]
12. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
Pujol-Autonell I; Serracant-Prat A; Cano-Sarabia M; Ampudia RM; Rodriguez-Fernandez S; Sanchez A; Izquierdo C; Stratmann T; Puig-Domingo M; Maspoch D; Verdaguer J; Vives-Pi M
PLoS One; 2015; 10(6):e0127057. PubMed ID: 26039878
[TBL] [Abstract][Full Text] [Related]
13. The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.
Devi KS; Anandasabapathy N
Semin Immunopathol; 2017 Feb; 39(2):137-152. PubMed ID: 27888331
[TBL] [Abstract][Full Text] [Related]
14. Tolerogenic dendritic cells.
Takenaka MC; Quintana FJ
Semin Immunopathol; 2017 Feb; 39(2):113-120. PubMed ID: 27646959
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes.
Villalba A; Rodriguez-Fernandez S; Ampudia RM; Cano-Sarabia M; Perna-Barrull D; Bertran-Cobo C; Ehrenberg C; Maspoch D; Vives-Pi M
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):77-83. PubMed ID: 31852325
[TBL] [Abstract][Full Text] [Related]
16. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
17. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
18. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
Front Immunol; 2018; 9():290. PubMed ID: 29503651
[TBL] [Abstract][Full Text] [Related]
19. Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity.
Pujol-Autonell I; Ampudia RM; Planas R; Marin-Gallen S; Carrascal J; Sanchez A; Marin A; Puig-Domingo M; Pujol-Borrell R; Verdaguer J; Vives-Pi M
PLoS One; 2013; 8(5):e63296. PubMed ID: 23691013
[TBL] [Abstract][Full Text] [Related]
20. Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.
Buckner JH; Nepom GT
J Autoimmun; 2016 Jul; 71():44-50. PubMed ID: 26948997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
